Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 163 results found. Search for [ Department of Biotechnology ]

Results 1 to 21 of 163
April 23, 2021
Johnson & Johnson vaccines are expected to be imported to India by June-July 2021 Johnson & Johnson is working closely with Biological E to facilitate the ongoing tech transfer to India, Renu Swarup, Secretary, Department of Biotechnology said

April 21, 2021
Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India

April 16, 2021
The Centre is providing financial support as grant to vaccine manufacturing facilities to enhance their production capacities.

April 16, 2021
In a letter to Maharashtra Chief Secretary Sitaram Kunte, Renu Swarup, Secretary in Department of Biotechnology, said Haffkine Institute can manufacture the vaccine doses.

PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year

Joe C Mathew
February 18, 2021
The findings of their study, published in Biochemistry, the peer-review Journal of the American Chemical Society, say that introducing electrostatic interaction sites on potential drug molecules can enhance the efficacy of the antiviral drug against the HIV virus

February 17, 2021
The vaccines currently approved for emergency use in India are Covishield, from the Oxford-AstraZeneca stable manufactured by Pune's Serum Institute of India, and Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV)

February 15, 2021
Scientists are working with an anti-viral coating technology called DiOX, which uses organic disinfectant compounds in the textiles, says report

January 30, 2021
The review, of more than 40 publicly available documents and research papers in Chinese and English, shows BGI's links to the People's Liberation Army (PLA) include research with China's top military supercomputing experts

January 6, 2021
(For) all our vaccines, we are looking at right now..(we) are targeting 2-8 degree because our logistics are worked out on that basis and we are working on that, DBT secretary Renu Swarup said at a press briefing

January 3, 2021
COVID-19 vaccine in India: It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, said PM Modi

December 24, 2020
This week, NITI Aayog member (health) Dr V K Paul also said that there was no need to panic over the mutated variant of SARS-CoV-2. Paul said the mutated strain detected in the UK will have no impact on the potential of emerging vaccines

December 19, 2020
Moderna COVID-19 Vaccine: 20 million doses will be delivered by the end of December 2020; total 200 million doses have been ordered by the US government to date, says the company

December 17, 2020
Alka Sharma, an adviser with the Department of Biotechnology said more than 100 participants from Afghanistan, Bhutan, Maldives, Mauritius, Nepal, Sri Lanka took part in this training programme

December 11, 2020
The mRNA vaccine candidate -  HGCO19 - is being developed by Pune-based company Gennova, and is supported with seed grant under the Ind-CEPI mission of Department of Biotechnology under Ministry of Science and Technology

Joe C Mathew
December 9, 2020
AIDAN wanted to know the exact processes and parameters for restricted emergency use approval of COVID-19 vaccine candidates in India, and whether and under what conditions interim results can be sufficient for seeking such an approval

December 8, 2020
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation

December 1, 2020
Dr. Reddy's and RDIF had partnered up in September 2020, so as to conduct clinical trials of the Sputnik V vaccine, as well as having the rights for distribution of its first 100 million doses in India.

Vivek Punj
New Delhi, December 1, 2020
Reliance confirms buying stake in lingerie retailer ZivameReliance Industries (RIL), in an exchange filing, confirmed that it has acquired a minority stake in Actoserba Active Wholesale, which owns and operates online lingerie store Zivame. The transaction was concluded in the first half year ended September 30, 2020.COVID-19: RT-PCR tests in Delhi to cost Rs 800The Arvind Kejriwal government on Monday ordered all private laboratories to reduce the price of RT-PCR tests in the national cap...

Chitranjan Kumar
November 30, 2020
Primary efficacy analysis of the Phase 3 COVE study of Moderna' COVID-19 vaccine involved 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe

PAGES 1 OF 9  12345